Literature DB >> 17873900

Chromosomal and methylation alterations in sporadic and familial adenomatous polyposis-related duodenal carcinomas.

Marloes Berkhout1, Iris D Nagtegaal, Sandra J B Cornelissen, Marieke M G Dekkers, Fred J J M van de Molengraft, Wilbert H M Peters, Fokko M Nagengast, J Han J M van Krieken, Judith W M Jeuken.   

Abstract

Primary carcinomas of the small intestine are rare and the mechanism of their pathogenesis is poorly understood. Patients with familial adenomatous polyposis (FAP) have a high risk of developing duodenal carcinomas. The aim of this study is to gain more insight into the development of duodenal carcinomas. Therefore, five FAP-related duodenal carcinomas were characterized for chromosomal and methylation alterations, which were compared to those observed in sporadic duodenal carcinomas. Comparative genomic hybridization (CGH) and methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) was performed in 10 primary sporadic and five primary FAP-related duodenal carcinomas. In the FAP-related carcinomas, frequent gains were observed on chromosomes 8, 17 and 19, whereas in sporadic carcinomas they occurred on chromosomes 8, 12, 13 and 20. In 60% of the sporadic carcinomas, gains in the regions of chromosome 12 were observed which were absent in the FAP-related carcinomas (P=0.04). Hypermethylation was observed in the immunoglobulin superfamily genes member 4 (IGSF4), TIMP metallopeptidase inhibitor 3 (TIMP3), Estrogen receptor 1 (ESR1), adenomatous polyposis coli (APC), H-cadherin (CDH13) and paired box gene 6 (PAX6) genes. Hypermethylation of PAX6 was only observed in FAP-related carcinomas (3/5) and not in sporadic carcinomas (P=0.02). In conclusion, in contrast to sporadic duodenal carcinomas, gains on chromosome 12 were not observed in duodenal carcinomas of patients with FAP. Identification of the genes in these regions of chromosome 12 could lead to a better understanding of the carcinogenesis pathways leading to sporadic and FAP-related duodenal carcinomas. Furthermore, hypermethylation seems to be a general feature of both FAP-related duodenal carcinomas as well as sporadic duodenal carcinomas with the exception of the PAX6 gene, which is methylated only in FAP-related carcinomas.

Entities:  

Mesh:

Year:  2007        PMID: 17873900     DOI: 10.1038/modpathol.3800952

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  10 in total

1.  MLH1 promoter hypermethylation in the analytical algorithm of Lynch syndrome: a cost-effectiveness study.

Authors:  Mireia Gausachs; Pilar Mur; Julieta Corral; Marta Pineda; Sara González; Llúcia Benito; Mireia Menéndez; Josep Alfons Espinàs; Joan Brunet; María Dolores Iniesta; Stephen B Gruber; Conxi Lázaro; Ignacio Blanco; Gabriel Capellá
Journal:  Eur J Hum Genet       Date:  2012-01-25       Impact factor: 4.246

2.  Multiplexed methylation profiles of tumor suppressor genes in bladder cancer.

Authors:  Maria José Cabello; Laura Grau; Noreli Franco; Esteban Orenes; Miguel Alvarez; Ana Blanca; Oscar Heredero; Alberto Palacios; Manuel Urrutia; Jesus María Fernández; Antonio López-Beltrán; Marta Sánchez-Carbayo
Journal:  J Mol Diagn       Date:  2010-12-23       Impact factor: 5.568

3.  Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer.

Authors:  Mónica Castro; Laura Grau; Patricia Puerta; Liliana Gimenez; Julio Venditti; Silvia Quadrelli; Marta Sánchez-Carbayo
Journal:  J Transl Med       Date:  2010-09-17       Impact factor: 5.531

4.  Methylation-specific multiplex ligation-dependent probe amplification in meningiomas.

Authors:  Christian Ewald; Thomas Hofmann; Susanne A Kuhn; Thomas Deufel; Christian Beetz; Rolf Kalff
Journal:  J Neurooncol       Date:  2008-09-02       Impact factor: 4.130

Review 5.  Molecular approach to genetic and epigenetic pathogenesis of early-onset colorectal cancer.

Authors:  Gulcin Tezcan; Berrin Tunca; Secil Ak; Gulsah Cecener; Unal Egeli
Journal:  World J Gastrointest Oncol       Date:  2016-01-15

6.  Methylation-specific multiplex ligation-dependent probe amplification and its impact on clinical findings in medulloblastoma.

Authors:  Denise Feierabend; Jan Walter; Susanne Grube; Christian Herbold; Christian Beetz; Rolf Kalff; Christian Ewald
Journal:  J Neurooncol       Date:  2013-10-27       Impact factor: 4.130

Review 7.  Use of the MLPA assay in the molecular diagnosis of gene copy number alterations in human genetic diseases.

Authors:  Liborio Stuppia; Ivana Antonucci; Giandomenico Palka; Valentina Gatta
Journal:  Int J Mol Sci       Date:  2012-03-08       Impact factor: 6.208

8.  Downregulation of PAX6 by shRNA inhibits proliferation and cell cycle progression of human non-small cell lung cancer cell lines.

Authors:  Xiaoting Zhao; Wentao Yue; Lina Zhang; Li Ma; Wenyun Jia; Zhe Qian; Chunyan Zhang; Yue Wang
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

9.  Clinical Value and Prospective Pathway Signaling of MicroRNA-375 in Lung Adenocarcinoma: A Study Based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and Bioinformatics Analysis.

Authors:  Ting-Qing Gan; Wen-Jie Chen; Hui Qin; Su-Ning Huang; Li-Hua Yang; Ye-Ying Fang; Lin-Jiang Pan; Zu-Yun Li; Gang Chen
Journal:  Med Sci Monit       Date:  2017-05-23

10.  The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K/AKT signaling.

Authors:  Dong-Ming Wu; Ting Zhang; Ya-Bin Liu; Shi-Hua Deng; Rong Han; Teng Liu; Jing Li; Ying Xu
Journal:  Cell Death Dis       Date:  2019-04-25       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.